How to Balance Hormones Before Pregnancy

Why Preconception Hormone Balance Matters

Hormone optimization before conception reduces miscarriage risk, shortens time to pregnancy, and protects fetal development during the first trimester. Starting this work three to six months in advance gives clinicians enough time to identify problems, titrate medications, and confirm that levels have stabilized before a pregnancy test turns positive.

The data supporting preconception care is strong. A 2019 Lancet series on preconception health estimated that nearly half of pregnancies worldwide are unplanned, meaning many women enter pregnancy with undiagnosed thyroid dysfunction, insulin resistance, or vitamin deficiencies 1. The American College of Obstetricians and Gynecologists (ACOG) recommends that all women of reproductive age receive preconception counseling, including hormone and metabolic screening, as part of routine care 2. This is not optional fine-tuning. It is preventive medicine with measurable downstream effects on both maternal and neonatal outcomes.

Thyroid Function: The First Hormone to Check

Thyroid hormones regulate ovulation, implantation, and fetal brain development, making thyroid screening the single highest-yield preconception test. The Endocrine Society recommends a preconception TSH target of <2.5 mIU/L for women planning pregnancy 3.

Subclinical hypothyroidism, defined as TSH between 2.5 and 10 mIU/L with normal free T4, affects 4 to 8 percent of reproductive-age women 4. A 2017 meta-analysis in Human Reproduction Update (N=47,045) found that even mildly elevated TSH was associated with a 35 percent increase in miscarriage risk 5. Women already on levothyroxine typically need a dose increase of 25 to 50 percent once pregnant, so establishing a stable baseline dose beforehand matters.

The American Thyroid Association (ATA) recommends checking TSH, free T4, and thyroid peroxidase (TPO) antibodies before conception. TPO-positive women have a two-fold higher miscarriage rate even when TSH is normal 5. If antibodies are present, some endocrinologists start low-dose levothyroxine (25 to 50 mcg) prophylactically. Dr. Erik Alexander, former chair of the ATA Pregnancy Guidelines Task Force, has stated: "The thyroid gland is under significant stress during early pregnancy, and women with limited thyroid reserve may not be able to meet the increased demand" 3.

Progesterone and the Luteal Phase

Progesterone sustains the uterine lining after ovulation, and low levels in the luteal phase are one of the most common correctable causes of early pregnancy loss. A midluteal serum progesterone above 3 ng/mL confirms that ovulation occurred, but levels above 10 ng/mL are associated with better implantation outcomes 6.

Luteal phase deficiency (LPD) can result from stress, PCOS, hyperprolactinemia, or thyroid dysfunction. The fix depends on the root cause. For isolated LPD, supplemental progesterone (vaginal micronized progesterone 200 mg nightly starting 3 days post-ovulation) is a well-studied intervention. The PROMISE trial (N=836), published in the New England Journal of Medicine, evaluated progesterone supplementation in women with recurrent miscarriage and found a live birth rate of 65.8 percent in the progesterone group versus 63.3 percent with placebo 7. That trial was not statistically significant in the overall population, but a pre-specified subgroup of women with three or more prior losses showed a meaningful benefit (72 percent vs. 57 percent live birth rate).

Tracking basal body temperature and using ovulation predictor kits can reveal whether the luteal phase is consistently shorter than 10 days, which warrants formal progesterone testing on cycle day 21.

Insulin and Blood Sugar: The Overlooked Driver

Insulin resistance disrupts ovulation, raises androgens, and increases miscarriage risk. It is not limited to women with diabetes. A 2020 study in Fertility and Sterility found that fasting insulin above 10 µIU/mL was independently associated with longer time to pregnancy, even in women with regular cycles 8.

The mechanism is straightforward. Excess insulin stimulates ovarian theca cells to produce more testosterone, which interferes with follicle maturation. This same pathway drives anovulation in PCOS. Interventions that improve insulin sensitivity (metformin, inositol, dietary changes, exercise) can restore ovulatory function.

Metformin at doses of 1,500 to 2,000 mg daily has been shown to restore ovulation in up to 46 percent of anovulatory PCOS cycles 9. Myo-inositol (4 g/day) combined with D-chiro-inositol (0.1 g/day) in a 40:1 ratio has demonstrated comparable effects on insulin sensitivity and ovulation in several randomized trials 10. Dietary approaches emphasizing lower glycemic load, adequate protein (1.2 to 1.6 g/kg), and regular resistance training also reduce fasting insulin within 8 to 12 weeks.

Preconception labs should include fasting glucose, fasting insulin, and hemoglobin A1c. A HOMA-IR score above 2.0 suggests clinically relevant insulin resistance.

Androgens: Addressing PCOS Before Conception

Polycystic ovary syndrome affects 8 to 13 percent of reproductive-age women globally, according to the international evidence-based PCOS guideline endorsed by ESHRE, ASRM, and multiple other societies 11. High androgens cause irregular cycles, anovulation, and poor oocyte quality, all of which reduce fertility.

The preconception priority is restoring ovulatory cycles. Spironolactone, commonly used for androgen-related acne and hirsutism, must be discontinued at least one month before attempting conception due to its anti-androgenic effects on male fetal development. The FDA classifies it as pregnancy category X 12. Women on combined oral contraceptives for PCOS management should stop the pill two to three months before trying to conceive, as it may take one to three cycles for regular ovulation to resume.

Weight loss of 5 to 10 percent of body weight in women with a BMI above 30 has been shown to restore spontaneous ovulation in 30 to 50 percent of PCOS cases 11. Letrozole, now the first-line ovulation induction agent (replacing clomiphene per ASRM guidelines), achieves live birth rates of 27.5 percent per cycle compared to 19.1 percent for clomiphene, based on the NICHD Reproductive Medicine Network trial (N=750) 13.

Cortisol, Stress, and the HPA Axis

Chronic stress elevates cortisol, which suppresses GnRH pulsatility and can reduce luteal phase progesterone. This is the physiological basis of "stress-related" cycle irregularity. It is not psychological. It is neuroendocrine.

A 2014 study in Human Reproduction (N=501 couples) measured salivary alpha-amylase, a biomarker of sympathetic nervous system activation, and found that women in the highest stress quartile had a 29 percent reduction in fecundability compared to the lowest quartile 14. The authors concluded that stress reduction should be incorporated into preconception counseling.

Functional hypothalamic amenorrhea (FHA) represents the extreme end of this spectrum. It occurs when energy deficit, excessive exercise, or psychological stress suppresses GnRH to the point of complete anovulation. The Endocrine Society's clinical practice guideline for FHA recommends cognitive behavioral therapy, caloric restoration, and reduction in exercise intensity as first-line treatments 15. Exogenous hormones (estrogen/progesterone) mask the problem without restoring fertility.

Sleep, targeted stress management (structured relaxation practices, workload modification), and adequate caloric intake are the primary interventions. Cortisol testing (morning serum or four-point salivary cortisol) can identify women with dysregulated HPA axis output.

Prolactin: A Quiet Disruptor of Ovulation

Elevated prolactin suppresses GnRH, which in turn reduces FSH and LH pulsatility. The result is anovulation or luteal phase deficiency. Prolactin levels above 25 ng/mL warrant investigation, and levels above 100 ng/mL raise concern for a pituitary adenoma 16.

Common causes of mild hyperprolactinemia include hypothyroidism (which increases TRH, a prolactin secretagogue), certain medications (SSRIs, antipsyctics, metoclopramide, domperidone), and stress. Correcting the underlying cause often normalizes prolactin without additional treatment.

When medication is needed, cabergoline (0.25 to 1 mg twice weekly) is preferred over bromocriptine for its superior efficacy and tolerability. The Endocrine Society's 2011 Clinical Practice Guideline for hyperprolactinemia recommends cabergoline as first-line pharmacotherapy, noting that it normalizes prolactin in approximately 90 percent of patients 16. Dr. Shlomo Melmed, a leading pituitary endocrinologist at Cedars-Sinai, has noted: "Cabergoline is highly effective for restoring ovulatory function in hyperprolactinemic women, and pregnancy outcomes are reassuring based on available surveillance data" 16.

Key Labs to Request Three to Six Months Before Conceiving

A targeted preconception hormone panel should include the following tests, drawn on cycle day 2 to 4 unless otherwise specified: TSH, free T4, free T3, TPO antibodies, FSH, LH, estradiol, total and free testosterone, DHEA-S, prolactin, fasting insulin, fasting glucose, HbA1c, 25-hydroxyvitamin D, and a complete metabolic panel 2.

Midluteal progesterone (cycle day 21 in a 28-day cycle, adjusted for longer or shorter cycles) should be drawn separately. AMH (anti-Müllerian hormone) provides information about ovarian reserve and is particularly useful for women over 35 or those with a history of ovarian surgery.

Vitamin D deserves specific attention. A meta-analysis of 11 studies (N=2,700) published in the Journal of Clinical Endocrinology and Metabolism found that vitamin D deficiency (<20 ng/mL) was associated with a 44 percent higher risk of miscarriage 17. The target for preconception is 40 to 60 ng/mL, typically requiring 2,000 to 5,000 IU daily of vitamin D3 for repletion.

Iron studies (ferritin, serum iron, TIBC) and a CBC also belong in this panel. Ferritin below 30 ng/mL indicates depleted stores even if hemoglobin is normal, and iron deficiency is linked to anovulation and poor pregnancy outcomes 18.

Nutrition and Lifestyle Interventions

The evidence base for preconception nutrition is anchored by three consistent findings: folic acid supplementation reduces neural tube defects, Mediterranean-style dietary patterns improve fertility, and adequate protein intake supports hormonal signaling.

ACOG recommends 400 to 800 mcg of folic acid daily, starting at least one month before conception 2. Women with MTHFR variants or a history of neural tube defects should take methylfolate (L-5-MTHF) at 1 mg daily or higher doses as directed. A 2018 systematic review in Reproductive BioMedicine Online analyzed dietary patterns and fertility outcomes across 9 prospective studies (N=22,630) and found that women with the highest adherence to a Mediterranean diet had a 66 percent lower risk of anovulatory infertility 19.

Alcohol should be eliminated during the preconception period. Even moderate intake (3 to 6 drinks per week) has been associated with reduced fecundability in prospective cohort studies 20. Caffeine intake should remain below 200 mg per day, consistent with ACOG guidance.

Exercise at moderate intensity (150 minutes per week) improves insulin sensitivity and ovulation regularity. Excessive exercise (more than 60 minutes of high-intensity activity daily) can suppress the HPO axis and should be reduced in women with irregular cycles or amenorrhea 15.

Medications That May Need Adjustment

Several commonly prescribed medications require modification or discontinuation before conception. The timeline for each varies.

Spironolactone must stop at least one month before conception (Category X) 12. Statins (atorvastatin, rosuvastatin) should be discontinued as they are contraindicated in pregnancy. ACE inhibitors and ARBs require switching to pregnancy-safe antihypertensives (labetalol, nifedipine, or methyldopa) before conception, as they carry risk of renal agenesis and fetal malformation in the second and third trimesters 21.

Levothyroxine should be continued and the dose reviewed. The ATA recommends that women increase their dose by approximately 30 percent as soon as pregnancy is confirmed, so preconception TSH should be in the lower half of the reference range 3. Metformin can be continued through conception and into the first trimester for women with PCOS or insulin resistance, as it is classified as Category B and has extensive safety data.

SSRIs require individual risk-benefit analysis. Sertraline and escitalopram have the most reassuring pregnancy safety profiles among antidepressants. Abrupt discontinuation increases the risk of relapse, so tapering should be supervised by the prescribing provider.

Timeline: When to Start and What to Prioritize

Six months before conception is ideal for starting lab work, initiating medication changes, and allowing time for dose adjustments. Three months is the minimum for thyroid optimization, as TSH stabilization after a levothyroxine dose change takes 6 to 8 weeks, and a recheck adds another cycle.

The priority order: thyroid first (slowest to titrate), then insulin and metabolic health, then progesterone and ovulatory function. Nutritional changes (folic acid, vitamin D, iron) can begin immediately. Medication switches (spironolactone, statins, ACE inhibitors) should happen as soon as the decision to conceive is made, with appropriate therapeutic alternatives in place.

Women over 35 should have AMH and day-3 FSH checked early. An AMH below 1.0 ng/mL or FSH above 10 mIU/L may prompt earlier referral to a reproductive endocrinologist rather than extended preconception optimization 22.

A follow-up lab panel 8 to 12 weeks after initiating any change confirms that levels have reached target before active attempts at conception begin.